Skip to main content

Mitochondria and Cancer

From Basic Science to Clinical Applications – Understanding Pathogenesis, Therapy Resistance, and Disease Relapse

  • 1st Edition - February 13, 2026
  • Latest edition
  • Editors: Farzad Taghizadeh-Hesary, Sumel Ashique, Babak Behnam, Maria Vliora
  • Language: English

Mitochondria and Cancer: From Basic Science to Clinical Applications—Understanding Pathogenesis, Therapy Resistance, and Disease Relapse offers comprehensive perspectives… Read more

Black Friday

Up to 40% off trusted resources

Black Friday savings are here

Description

Mitochondria and Cancer: From Basic Science to Clinical Applications—Understanding Pathogenesis, Therapy Resistance, and Disease Relapse offers comprehensive perspectives about the role of mitochondria in cancer biology and treatment. This book integrates fundamental scientific knowledge with clinical relevance, presenting recent findings that will engage oncology researchers and provide valuable recommendations for cancer prevention and prognosis. In response to the rising global cancer incidence, this book serves as a comprehensive guide to mitochondrial metabolism in oncology, furthering cancer study and management. It explores a wide range of topics that highlight the multifaceted role of mitochondria in cancer, including tumor microenvironment, cancer stem cells, microbiota, resistance mechanisms, mitochondria-enhancing strategies, and targeted therapies. It includes technical details, research findings, and discussions on the implications of mitochondrial research in cancer treatment and management. Its distinguishing aspects include its comprehensive coverage and diverse perspectives from global experts, providing a well-rounded view of current research.

Key features

  • Delivers an in-depth analysis of how mitochondrial alterations contribute to cancer formation, disease progression, and resistance to conventional and targeted therapies
  • Presents comprehensive insights into the dynamic interactions between mitochondria in cancer cells, tumor microenvironment, and microbiota, highlighting their collective influence on cancer progression and therapeutic outcomes
  • Combines fundamental scientific knowledge with clinical relevance, covering a wide array of topics from mitochondrial metabolism to innovative therapeutic strategies

Readership

Researchers in oncology, molecular biology, clinical oncology, and biomedical research

Table of contents

1. Mitochondria: Origin, Structure, and Function

2. Mitochondrial Metabolism and Trafficking in Cancer

3. Mitochondrial Genome and Cancer

4. Mitochondrial-nuclear Crosstalk and Its Role in Cancer

5. Mitochondria and Tumor Microenvironment

6. Mitochondria and Cancer Stem Cells

7. Mitochondria, Exosome, Cancer

8. Mitochondria, Microbiota, Cancer

9. MiRNAs and Their Impacts on Cancer Cell’s Mitochondria

10. Mitochondria and Cancer Prevention

11. Mitochondria and Cancer Diagnosis

12. Mitochondrial Metabolism as a Prognostic Biomarker (Mitochondria and Cancer Progression)

13. Mitochondria, Tumor Microenvironment, and Radioresistance

14. Mitochondria and Resistance to Chemotherapy

15. Mitochondria and Resistance to Targeted Therapies

16. Mitochondria and Resistance to Immunotherapy

17. Mitochondria Enhancing Strategies in Cancer

18. Advances in Targeted Anti-mitochondrial Therapies

19. Applying Magnetic Fields to Target Mitochondria

20. what the Artificial Intelligence (AI) Proposes for the Mitochondria Role in Cancer

Product details

  • Edition: 1
  • Latest edition
  • Published: February 14, 2026
  • Language: English

About the editors

Farzad Taghizadeh-Hesary

Editor

Dr. Farzad Taghizadeh-Hesary is an Assistant Professor of Radiation Oncology at Iran University of Medical Sciences, specializing in oncology, radiobiology, and cancer metabolism. He earned his M.D. in 2015 from IUMS and completed a Radiation Oncology residency at Shahid Beheshti University of Medical Sciences, ranking among the top graduates nationally. His thesis examined late toxicities after IMRT for nasopharyngeal carcinoma, reflecting a commitment to precision radiotherapy.

His expertise spans clinical and academic oncology, with a focus on tumor microenvironment and mitochondrial metabolism in cancer. He has published more than 80 peer-reviewed articles and serves on editorial boards including BMC Cancer and PLoS ONE. Awards include the Razi Medical Science Research Prize and the Outstanding Reviewer Award from JCO Clinical Cancer Informatics; Publons Academy ranked him the top global Radiation Oncology reviewer in 2021.

His research centers on personalized radiotherapy, cancer immunotherapy, and metabolic interventions targeting mitochondrial dysfunction, advancing translational oncology

Affiliations and expertise
Iran University of Medical Sciences, Tehran, Iran

Sumel Ashique

Editor
Dr. Sumel Ashique is an Assistant Professor in the Department of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, West Bengal, India. His academic and research activities focus on drug delivery systems, nanotechnology, and targeted therapeutic strategies. He has several years of teaching experience and has contributed extensively to the scientific literature through publications in national and international peer-reviewed journals. His work centers on the development and application of innovative approaches to improve therapeutic outcomes and advance pharmaceutical sciences.

Affiliations and expertise
Department of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, Kolkata, West Bengal, India

Babak Behnam

Editor
Dr. Babak Behnam is a scientist with expertise spanning human genetics, genomics, biochemical genetics, and clinical research. He has held research positions at University College London, the University of Michigan School of Medicine, the University of Central Florida, and the National Institutes of Health, including work with the Undiagnosed Diseases Program and the National Human Genome Research Institute. His research interests focus on translational science, neuroscience and neurogenetics, and the biochemical and molecular mechanisms of disease, with an emphasis on the application of advanced genomic technologies and next-generation sequencing platforms. Dr. Behnam has authored numerous peer-reviewed publications, is an inventor on multiple patents, and has served on the editorial boards of several scientific journals. His professional interests also include clinical research and the regulatory and scientific evaluation of clinical trials.

Affiliations and expertise
• American University, College of Arts and Sciences, Department of Biology, Washington, DC, USA • The Floret Center, Advanced Genomics & Bioinformatics Research Center, Lagos, Nigeria

Maria Vliora

Editor
Dr. Vliora Maria is a Molecular Biologist with extensive background in molecular biology and integrative physiology. She has previously studied mutations of immunoglobulins in Chronic Lymphocytic Leukemia patients, and ALK mutations and downstream signaling in Neuroblastoma. Dr. Vliora has a PhD in Biomedical Research from University of Thessaly, Greece and University of Brescia, Italy. She has worked on the development of biocompatible/biodegradable bioscaffolds for targeting adipose tissue as well as on potential nanomedical treatments for brain tumors as well as blood malignancies. Her research work is now focusing on environmental influences that can affect human health and on the use of novel biodegradable bio-scaffolds for allografting adipose stem cells in humans. She collaborated with reputable organizations (WHO, ILO) on projects aiming to enhance human health and wellbeing. She now works as a Project Manager on EU funded projects.
Affiliations and expertise
FAME Laboratory, Department of Physical Education and Sport Science, University of Thessaly, Trikala, Greece

View book on ScienceDirect

Read Mitochondria and Cancer on ScienceDirect